{
  "status" : "final",
  "category" : {
    "text" : "Laboratory",
    "coding" : [
      {
        "system" : "http://hl7.org/fhir/observation-category",
        "display" : "Laboratory",
        "code" : "laboratory"
      }
    ]
  },
  "issued" : "2021-08-11T10:27:00Z",
  "id" : "TqHcFQ6RSPUcuR5yP3s0lCLIzlLSbTtOi5TBnqG503i3Z8uc-u627m4ojFir--ERzB",
  "code" : {
    "text" : "HX NON HDL CHOL (LDL+VLDL)"
  },
  "valueQuantity" : {
    "code" : "mg/dL",
    "value" : 162,
    "system" : "http://unitsofmeasure.org",
    "unit" : "mg/dL"
  },
  "subject" : {
    "display" : "Lopez, James Joel",
    "reference" : "https://epicproxy.et0905.epichosted.com/FHIRProxy/api/FHIR/DSTU2/Patient/TrS7pTeyWII9cw-xxl5jDrPczC4c5dkg8XOYg4BocZ84B"
  },
  "comments" : "Treatment Goals:Extreme Risk:       <80 mg/dLVery High Risk:     <100 mg/dLHigh Risk:          <130 mg/dLModerate Risk:      <130 mg/dLLow Risk:           <160 mg/dLAmerican Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of dyslipidemia and prevention of cardiovascular disease.  Endocrine Practice Vol 23 (Sup 2) April 2017.",
  "effectiveDateTime" : "2021-08-11T10:27:00Z",
  "resourceType" : "Observation"
}